Intrinsic Value of S&P & Nasdaq Contact Us

Everus Construction Group, Inc. ECG NYSE

NYSE • Industrials • Engineering & Construction • US • USD

SharesGrow Score
62/100
3/7 Pass
SharesGrow Intrinsic Value
$56.88
-58.1%
Analyst Price Target
$107.25
-21%

Everus Construction Group, Inc. (ECG) is a Engineering & Construction company in the Industrials sector, currently trading at $135.77. It has a SharesGrow Score of 62/100, indicating a above average investment profile with 3 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of ECG = $56.88 (-58.1% from the current price, the stock appears overvalued). Analyst consensus target is ECG = $107 (-21% upside).

Valuation: ECG trades at a trailing Price-to-Earnings (P/E) of 33.1 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 3.07.

Financials: revenue is $3.7B, +12.3%/yr average growth. Net income is $202M, growing at +18.4%/yr. Net profit margin is 5.4% (thin). Gross margin is 12.1% (+1.9 pp trend).

Balance sheet: total debt is $106M against $630M equity (Debt-to-Equity (D/E) ratio 0.17, conservative). Current ratio is 1.76 (strong liquidity). Debt-to-assets is 6.1%. Total assets: $1.7B.

Analyst outlook: 3 / 4 analysts rate ECG as buy (75%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 20/100 (Fail), Growth 80/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 42/100 (Fail), Future 49/100 (Partial), Income 45/100 (Partial).

$107.25
▼ 21.01% Downside
Average Price Target
Based on 4 Wall Street analysts offering 12-month price targets for Everus Construction Group, Inc., the average price target is $107.25, with a high forecast of $115.00, and a low forecast of $102.00.
Highest Price Target
$115.00
Average Price Target
$107.25
Lowest Price Target
$102.00

ECG SharesGrow Score Overview

62/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 20/100
Valuation — P/E, PEG, Forward PEG
GROWTH 80/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 42/100
Gross margin is + market cap
FUTURE 49/100
Analyst outlook — as buy
INCOME 45/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — ECG

VALUE Fail
20/100
ECG trades at a trailing Price-to-Earnings (P/E) of 33.1 (S&P 500 average ~25). Forward PEG 3.07 — overvalued. Trailing PEG 2.95. Analyst consensus target is $107, implying -21.2% from the current price $136. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
80/100
ECG: +12.3%/yr revenue is, +18.4%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
ECG: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Pass
100/100
Balance sheet ECG: Debt-to-Equity (D/E) ratio 0.17 (conservative), Current ratio is 1.76 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
MOAT Fail
42/100
ECG: Gross margin is 12.1% (+1.9 pp trend), $7B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 42/100. ≥ 70 = Pass.
View details →
~
FUTURE Partial
49/100
Analyst outlook: 3 / 4 analysts rate ECG as buy (75%). Analyst consensus target is $107 (-21.2% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
~
INCOME Partial
45/100
ECG: Net profit margin is 5.4%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range32.255-137.64
Volume757.74K
Avg Volume (30D)615.01K
Market Cap$6.93B
Beta (1Y)3.33
Share Statistics
EPS (TTM)3.94
Shares Outstanding$51.05M
IPO Date2024-10-28
Employees8,700
CEOJeffrey S. Thiede
Financial Highlights & Ratios
Revenue (TTM)$3.75B
Gross Profit$454.09M
EBITDA$324.33M
Net Income$201.77M
Operating Income$264.75M
Total Cash$170.5M
Total Debt$105.54M
Net Debt$-64.96M
Total Assets$1.73B
Price / Earnings (P/E)34.5
Price / Sales (P/S)1.85
Analyst Forecast
1Y Price Target$106.00
Target High$115.00
Target Low$102.00
Upside-21.9%
Rating ConsensusBuy
Analysts Covering4
Buy 75% Hold 25% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS3004261034

Price Chart

ECG
Everus Construction Group, Inc.  ·  NYSE
Industrials • Engineering & Construction
32.26 52WK RANGE 137.64
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message